Evolus Inc (EOLS)
13.04
+0.41
(+3.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.05
+0.01
(+0.08%)
After-Hours: 20:00
Evolus Profit Margin (Quarterly): -31.38% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -31.38% |
| June 30, 2024 | -16.96% |
| March 31, 2024 | -22.09% |
| December 31, 2023 | -19.40% |
| September 30, 2023 | -33.83% |
| June 30, 2023 | -36.76% |
| March 31, 2023 | -35.45% |
| December 31, 2022 | -30.16% |
| September 30, 2022 | -59.81% |
| June 30, 2022 | -63.16% |
| March 31, 2022 | -51.61% |
| Date | Value |
|---|---|
| December 31, 2021 | -52.45% |
| September 30, 2021 | -72.85% |
| June 30, 2021 | -59.78% |
| March 31, 2021 | 52.29% |
| December 31, 2020 | -538.0% |
| September 30, 2020 | -64.88% |
| June 30, 2020 | -270.6% |
| March 31, 2020 | -188.0% |
| December 31, 2019 | -74.60% |
| September 30, 2019 | -204.9% |
| June 30, 2019 | -1.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-538.0%
Minimum
Dec 2020
52.29%
Maximum
Mar 2021
-83.47%
Average
-52.03%
Median
Profit Margin (Quarterly) Benchmarks
| Insulet Corp | 14.25% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
| Myomo Inc | -10.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.72K% |
| Return on Assets | -26.50% |
| Return on Invested Capital | -47.66% |
| Gross Profit Margin (Quarterly) | 70.17% |
| Operating Margin (Quarterly) | -21.36% |
| Return on Net Operating Assets | -42.24% |